1. Combination Drug Therapy for the Management of Chronic Neuropathic Pain
   Serena Boccella et al, 2023, Biomolecules CrossRef
2. Synergism between gabapentin–tramadol in experimental diabetic neuropathic pain
   Hugo F. Miranda et al, 2018, Fundamental & Clinical Pharmacology CrossRef
3. Effect of repetitive transcranial magnetic stimulation on trigeminal‐mediated headshaking in 17 horses
   Vanessa Franzen et al, 2024, Journal of Veterinary Internal Medicine CrossRef
4. PnPP-15, a Synthetic Peptide Derived from a Toxin from Phoneutria nigriventer Spider Venom, Alleviates Diabetic Neuropathic Pain and Acts Synergistically with Pregabalin in Mice
   Xavier Maia Mariano et al, 2023, Toxins CrossRef
5. Endogenous opiates and behavior: 2017
   Richard J. Bodnar, 2020, Peptides CrossRef
6. Combination Therapy for Neuropathic Pain: A Review of Recent Evidence
   Ancor Serrano Afonso et al, 2021, Journal of Clinical Medicine CrossRef
7. Anti-neuropathic Pain Mechanistic Study on A. conyzoides Essential Oil, Precocene II, Caryophyllene, or Longifolene as Single Agents and in Combination with Pregabalin
   Y. Purwandi Sukmawan et al, 2023, CNS & Neurological Disorders - Drug Targets CrossRef
8. Synergistic interaction between haloperidol and gabapentin in a model of neuropathic nociception in rat
   Myrna Déciga-Campos et al, 2021, European Journal of Pharmacology CrossRef
9. Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials
   Igho J Onakpoya et al, 2019, BMJ Open CrossRef
10. Risk of major adverse events associated with gabapentinoid and opioid combination therapy: A systematic review and meta-analysis
    Jongsung Hahn et al, 2022, Frontiers in Pharmacology CrossRef